Molecule Details
| InChIKey | NZDSLYATTDIDPH-UHFFFAOYSA-N |
|---|---|
| Compound Name | Vevorisertib |
| Canonical SMILES | CC(=O)N(C)C1CCN(c2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)CC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 9.08 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB21481 |
|---|---|
| Drug Name | Vevorisertib |
| CAS Number | 1416775-46-6 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Vevorisertib is a small molecule drug. The usage of the INN stem '-sertib' in the name indicates that Vevorisertib is a serine/threonine kinase inhibitor. Vevorisertib is under investigation in clinical trial NCT02761694 (Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Can... |
Cross-references: CHEMBL4802156